Table 2.
mdr-1 polymorphisms in the 13 individuals*
| Patient | SAE | T282C | A781G | C1236T | C3151G | C3435T |
|---|---|---|---|---|---|---|
| 1 | No | T/T | A/A | C/C | C/C | C/C |
| 2 | No | T/T | A/A | C/C | C/G | C/C |
| 3 | No | C/C | A/A | C/C | C/C | C/C |
| 4 | No | T/T | A/A | C/C | C/C | C/T |
| 5 | No | T/T | A/A | C/T | C/C | T/T |
| 6 | No | T/T | A/A | C/C | C/C | C/C |
| 7 | No | T/T | A/A | C/C | C/C | C/C |
| 8 | No | T/T | A/A | C/T | C/C | T/T |
| 9 | No | T/T | A/G | C/T | C/C | C/T |
| 10 | Yes | T/T | A/A | T/T | C/C | T/T |
| 11 | Yes | T/T | A/A | T/T | C/C | T/T |
| 12 | Yes | T/T | A/A | CC | C/C | C/C |
| 13 | Yes | T/T | A/A | CC | C/C | C/C |
SAE = serious adverse event.